PMID- 26664025 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20151215 LR - 20201001 IS - 0973-1296 (Print) IS - 0976-4062 (Electronic) IS - 0973-1296 (Linking) VI - 11 IP - Suppl 2 DP - 2015 Oct TI - Xanthii Fructus inhibits allergic response in the ovalbumin-sensitized mouse allergic rhinitis model. PG - S352-61 LID - 10.4103/0973-1296.166058 [doi] AB - BACKGROUND: Xanthii Fructus (XF) is widely used in traditional anti-bacterial and anti-inflammatory Asian medicine. Allergic rhinitis is a common inflammatory disease characterized by markedly increased levels of anti-inflammatory factors and the recruitment of inflammatory cells into the nasal mucosa. We investigated the effects of XF in the allergen-induced rhinitis model. MATERIALS AND METHODS: Following ovalbumin (OVA)/alum intraperitoneal injection on days 0, 7 and 14, the BALB/c mice (albino, laboratory-bred strain of the house mice) were challenged intranasally with OVA for 10 days a week after the last sensitization. The number of sneezes was recorded for 10 days; additionally, the levels of cytokines, histamine, immunoglobulin E (IgE) and OVA-specific serum IgE were estimated. Eosinophil infiltration, thickness of nasal mucosa and expression of caspase-1 were determined by immunohistochemistry. We also evaluated the effect of XF on the phosphorylation of nuclear factor kappa-B (NF-kappaB) and inhibitor of nuclear factor kappa B-alpha (IkappaB-alpha) in human mast cell-1 (HMC-1), by Western blotting. RESULTS: The administration of XF significantly decreased sneezing and the serum levels of histamine, IgE, OVA-specific IgE, and cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukine-1 beta (IL-1beta), IL-5, IL-6, monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2). XF inhibited the changes in thickness of the nasal septum, influx of eosinophils and expression of capase-1. In addition, XF inhibited the phosphorylation of IkappaB-alpha and NF-kappaB in phorbol-myristate-acetate plus calcium ionophore A23187 (A23187) stimulated HMC-1. CONCLUSION: This study suggests that XF acts a potent anti-allergic drug which alleviates the allergic responses in ovalbumin-sensitized mouse allergic rhinitis model. FAU - Gwak, Nam-Gil AU - Gwak NG AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Kim, Eun-Young AU - Kim EY AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Lee, Bina AU - Lee B AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Kim, Jae-Hyun AU - Kim JH AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Im, Yong-Seok AU - Im YS AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Lee, Ka-Yeon AU - Lee KY AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Jun-Kum, Chang AU - Jun-Kum C AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Kim, Ho-Seok AU - Kim HS AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Cho, Hyun-Joo AU - Cho HJ AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Jung, Hyuk-Sang AU - Jung HS AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. FAU - Sohn, Youngjoo AU - Sohn Y AD - Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University, Seoul, Korea. LA - eng PT - Journal Article PL - United States TA - Pharmacogn Mag JT - Pharmacognosy magazine JID - 101300403 PMC - PMC4653347 OTO - NOTNLM OT - Allergic rhinitis OT - Xanthii Fructus OT - histamine OT - immunoglobulin E OT - nasal symptom OT - nuclear factor kappa-B COIS- Conflict of Interest: None declared. EDAT- 2015/12/15 06:00 MHDA- 2015/12/15 06:01 PMCR- 2015/10/01 CRDT- 2015/12/15 06:00 PHST- 2015/12/15 06:00 [entrez] PHST- 2015/12/15 06:00 [pubmed] PHST- 2015/12/15 06:01 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - PM-11-352 [pii] AID - 10.4103/0973-1296.166058 [doi] PST - ppublish SO - Pharmacogn Mag. 2015 Oct;11(Suppl 2):S352-61. doi: 10.4103/0973-1296.166058.